|
SAP130 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.067800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.190600E-01 |
| Normal-vs-Stage2 |
2.058200E-01 |
| Normal-vs-Stage3 |
5.616100E-02 |
| Normal-vs-Stage4 |
1.240370E-01 |
| Stage1-vs-Stage2 |
6.377500E-02 |
| Stage1-vs-Stage3 |
3.957600E-03 |
| Stage1-vs-Stage4 |
1.991730E-02 |
| Stage2-vs-Stage3 |
7.472400E-01 |
| Stage2-vs-Stage4 |
8.777000E-01 |
| Stage3-vs-Stage4 |
8.595200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.071200E-01 |
| Normal-vs-AfricanAmerican |
3.436600E-01 |
| Normal-vs-Asian |
3.794400E-02 |
| Caucasian-vs-AfricanAmerican |
5.807000E-01 |
| Caucasian-vs-Asian |
5.826000E-02 |
| AfricanAmerican-vs-Asian |
6.722000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.170100E-02 |
| Normal-vs-Female |
3.978600E-01 |
| Male-vs-Female |
2.482700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.919000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.364200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.321600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.526000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.995200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.380200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.536800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.686400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.132200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.629800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.644400E-03 |
| Normal-vs-Grade 2 |
9.692800E-01 |
| Normal-vs-Grade 3 |
2.869000E-01 |
| Normal-vs-Grade 4 |
4.017900E-02 |
| Grade 1-vs-Grade 2 |
1.672180E-02 |
| Grade 1-vs-Grade 3 |
5.519900E-03 |
| Grade 1-vs-Grade 4 |
1.957420E-03 |
| Grade 2-vs-Grade 3 |
1.934760E-01 |
| Grade 2-vs-Grade 4 |
1.742200E-02 |
| Grade 3-vs-Grade 4 |
1.590410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.675600E-02 |
| Normal-vs-ccB subtype |
3.019500E-02 |
| ccA subtype-vs-ccB subtype |
1.72411999999067E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.279600E-01 |
| Normal-vs-N1 |
8.714600E-01 |
| N0-vs-N1 |
6.355000E-01 |
|
|
